WCLC News

Drs. Keith Kerr and Sanja Dacic will examine the role of pathology in patient selection and specimen interpretation in the era of neoadjuvant immunotherapy.

Co-chair Dr. Pyng Lee said simply because a treatment has been approved does not make it an affordable and accessible clinical alternative for lung cancer patients in the real world.

Drs. Claudia Henschke and Pan-Chy Yang to chair an education session designed to help thoracic oncologists translate research into successful lung cancer screening efforts.

Drs. Hidehito Horinouchi and Stephen Liu will chair the session, which will explore multiple advances driving survival gains, including antibody-drug conjugates, bispecific T-cell engagers, and targeted therapies.

Members are invited to join the meeting and learn about the new plan, which will guide the association for the next 5 years.

In addition to thought-provoking keynotes from Her Royal Highness Princess Dina Mired and Dr. Gary Rodin, the official kickoff of #WCLC23 included a lively celebration of the meeting’s host city.

Investigator Dr. Ying Cheng says study results support the use of immunochemotherapy plus anti-angiogenesis as a new treatment option in a difficult-to-treat patient population.

Make time to visit the Exhibit Hall this evening to talk with poster presenters about their research.

The symposium also marks a change in IASLC leadership as Dr. Heather Wakelee will deliver the final Presidential Address of her term.

IASLC Staging and Prognostic Factors Committee Chair Dr. Hisao Asamura joins Drs. Valerie Rusch and Enrico Ruffini to review updates in lung cancer, mesothelioma, and thymic cancer.